|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJ
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vaccarella S, Lortet-Tieulent J, Plummer
M, Franceschi S and Bray F: Worldwide trends in cervical cancer
incidence: Impact of screening against changes in disease risk
factors. Eur J Cancer. 49:3262–3273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cole L and Stoler MH: Issues and
inconsistencies in the revised gynecologic staging systems. Semin
Diagn Pathol. 29:167–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berindan-Neagoe I, Monroig PC, Pasculli B
and Calin GA: MicroRNAome genome: A treasure for cancer diagnosis
and therapy. CA Cancer J Clin. 64:311–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gregory RI, Chendrimada TP, Cooch N and
Shiekhattar R: Human RISC couples microRNA biogenesis and
posttranscriptional gene silencing. Cell. 123:631–640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi JJ: New hope for a microRNA therapy
for liver cancer. Cell. 137:990–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wilting SM, Snijders PJ, Verlaat W,
Jaspers A, van De Wiel MA, van Wieringen WN, Meijer GA, Kenter GG,
Yi Y, le Sage C, et al: Altered microRNA expression associated with
chromosomal changes contributes to cervical carcinogenesis.
Oncogene. 32:106–116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu XM, Wang XB, Chen MM, Liu T, Li YX, Jia
WH, Liu M, Li X and Tang H: MicroRNA-19a and −19b regulate cervical
carcinoma cell proliferation and invasion by targeting CUL5. Cancer
Lett. 322:148–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang YD, Cai N, Wu XL, Cao HZ, Xie LL and
Zheng PS: OCT4 promotes tumorigenesis and inhibits apoptosis of
cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis.
4:e7602013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Gao G, Hu X, Wang Y, Schwarz JK,
Chen JJ, Grigsby PW and Wang X: Activation of miR-9 by human
papillomavirus in cervical cancer. Oncotarget. 5:11620–11630. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW,
Cheung AN, Pang RT and Yeung WS: miR-135a leads to cervical cancer
cell transformation through regulation of β-catenin via a
SIAH1-dependent ubiquitin proteosomal pathway. Carcinogenesis.
35:1931–1940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin W, Dong P, Ma C, Mitchelson K, Deng T,
Zhang L, Sun Y, Feng X, Ding Y, Lu X, et al: MicroRNA-133b is a key
promoter of cervical carcinoma development through the activation
of the ERK and AKT1 pathways. Oncogene. 31:4067–4075. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Long MJ, Wu FX, Li P, Liu M, Li X and Tang
H: MicroRNA-10a targets CHL1 and promotes cell growth, migration
and invasion in human cervical cancer cells. Cancer Lett.
324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F,
Xie X, Zhou C and Lu W: Suppressed miR-424 expression via
upregulation of target gene Chk1 contributes to the progression of
cervical cancer. Oncogene. 32:976–987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wan HY, Li QQ, Zhang Y, Tian W, Li YN, Liu
M, Li X and Tang H: MiR-124 represses vasculogenic mimicry and cell
motility by targeting amotL1 in cervical cancer cells. Cancer Lett.
355:148–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanehisa M, Araki M, Goto S, Hattori M,
Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T,
et al: KEGG for linking genomes to life and the environment.
Nucleic Acids Res. 36:D480–D484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
23
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gilabert-Estelles J, Braza-Boils A, Ramon
LA, Zorio E, Medina P, Espana F and Estelles A: Role of microRNAs
in gynecological pathology. Curr Med Chem. 19:2406–2413. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cortez MA, Bueso-Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body fluids -
the mix of hormones and biomarkers. Nat Rev Clin Oncol. 8:467–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Etheridge A, Lee I, Hood L, Galas D and
Wang K: Extracellular microRNA: A new source of biomarkers. Mutat
Res. 717:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Juan L, Tong HL, Zhang P, Guo G, Wang Z,
Wen X, Dong Z and Tian YP: Identification and characterization of
novel serum microRNA candidates from deep sequencing in cervical
cancer patients. Sci Rep. 4:62772014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y,
Chen YQ and Hong SJ: Differentially expressed microRNAs in the
serum of cervical squamous cell carcinoma patients before and after
surgery. J Hematol Oncol. 7:62014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bumrungthai S, Ekalaksananan T, Evans MF,
Chopjitt P, Tangsiriwatthana T, Patarapadungkit N, Kleebkaow P,
Luanratanakorn S, Kongyingyoes B, Worawichawong S, et al:
Up-regulation of miR-21 is associated with cervicitis and human
papillomavirus infection in cervical tissues. PLoS One.
10:e01271092015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shishodia G, Verma G, Srivastava Y,
Mehrotra R, Das BC and Bharti AC: Deregulation of microRNAs let-7a
and miR-21 mediate aberrant STAT3 signaling during human
papillomavirus-induced cervical carcinogenesis: Role of E6
oncoprotein. BMC Cancer. 14:9962014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shishodia G, Shukla S, Srivastava Y,
Masaldan S, Mehta S, Bhambhani S, Sharma S, Mehrotra R, Das BC and
Bharti AC: Alterations in microRNAs miR-21 and let-7a correlate
with aberrant STAT3 signaling and downstream effects during
cervical carcinogenesis. Mol Cancer. 14:1162015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee H, Kim KR, Cho NH, Hong SR, Jeong H,
Kwon SY, Park KH, An HJ, Kim TH, Kim I, et al: Gynecological
Pathology Study Group of the Korean Society of Pathologists:
MicroRNA expression profiling and Notch1 and Notch2 expression in
minimal deviation adenocarcinoma of uterine cervix. World J Surg
Oncol. 12:3342014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Levy C, Khaled M, Iliopoulos D, Janas MM,
Schubert S, Pinner S, Chen PH, Li S, Fletcher AL, Yokoyama S, et
al: Intronic miR-211 assumes the tumor suppressive function of its
host gene in melanoma. Mol Cell. 40:841–849. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Y, Brenn T, Brown ER, Doherty V and
Melton DW: Differential expression of microRNAs during melanoma
progression: miR-200c, miR-205 and miR-211 are downregulated in
melanoma and act as tumour suppressors. Br J Cancer. 106:553–561.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Asuthkar S, Velpula KK, Chetty C, Gorantla
B and Rao JS: Epigenetic regulation of miRNA-211 by MMP-9 governs
glioma cell apoptosis, chemosensitivity and radiosensitivity.
Oncotarget. 3:1439–1454. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bell RE, Khaled M, Netanely D, Schubert S,
Golan T, Buxbaum A, Janas MM, Postolsky B, Goldberg MS, Shamir R,
et al: Transcription factor/microRNA axis blocks melanoma invasion
program by miR-211 targeting NUAK1. J Invest Dermatol. 134:441–451.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boyle GM, Woods SL, Bonazzi VF, Stark MS,
Hacker E, Aoude LG, Dutton-Regester K, Cook AL, Sturm RA and
Hayward NK: Melanoma cell invasiveness is regulated by miR-211
suppression of the BRN2 transcription factor. Pigment Cell Melanoma
Res. 24:525–537. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mazar J, DeYoung K, Khaitan D, Meister E,
Almodovar A, Goydos J, Ray A and Perera RJ: The regulation of
miRNA-211 expression and its role in melanoma cell invasiveness.
PLoS One. 5:e137792010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bao W, Wang HH, Tian FJ, He XY, Qiu MT,
Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-miR-204-5p
regulatory circuitry controls proliferation and invasion of
endometrial carcinoma cells. Mol Cancer. 12:1552013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cui ZH, Shen SQ, Chen ZB and Hu C: Growth
inhibition of hepatocellular carcinoma tumor endothelial cells by
miR-204-3p and underlying mechanism. World J Gastroenterol.
20:5493–5504. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun Z, Zhang T, Hong H, Liu Q and Zhang H:
miR-202 suppresses proliferation and induces apoptosis of
osteosarcoma cells by downregulating Gli2. Mol Cell Biochem.
397:277–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu Z, Kim J, He L, Creighton CJ, Gunaratne
PH, Hawkins SM and Matzuk MM: Functional analysis of miR-34c as a
putative tumor suppressor in high-grade serous ovarian cancer. Biol
Reprod. 91:1132014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang S, Li WS, Dong F, Sun HM, Wu B, Tan
J, Zou WJ and Zhou DS: KITLG is a novel target of miR-34c that is
associated with the inhibition of growth and invasion in colorectal
cancer cells. J Cell Mol Med. 18:2092–2102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Achari C, Winslow S, Ceder Y and Larsson
C: Expression of miR-34c induces G2/M cell cycle arrest in breast
cancer cells. BMC Cancer. 14:5382014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
van der Deen M, Taipaleenmäki H, Zhang Y,
Teplyuk NM, Gupta A, Cinghu S, Shogren K, Maran A, Yaszemski MJ,
Ling L, et al: MicroRNA-34c inversely couples the biological
functions of the runt-related transcription factor RUNX2 and the
tumor suppressor p53 in osteosarcoma. J Biol Chem. 288:21307–21319.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Engelbrecht AM, Gebhardt S and Louw L: Ex
vivo study of MAPK profiles correlated with parameters of apoptosis
during cervical carcinogenesis. Cancer Lett. 235:93–99. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gao LJ, Gu PQ, Zhao W, Ding WY, Zhao XQ,
Guo SY and Zhong TY: The role of globular heads of the C1q receptor
in HPV 16 E2-induced human cervical squamous carcinoma cell
apoptosis is associated with p38 MAPK/JNK activation. J Transl Med.
11:1182013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen TP, Chen CM, Chang HW, Wang JS, Chang
WC, Hsu SI and Cho CL: Increased expression of SKP2 and
phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor
progression of cervical neoplasms. Gynecol Oncol. 104:516–523.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Su PH, Lin YW, Huang RL, Liao YP, Lee HY,
Wang HC, Chao TK, Chen CK, Chan MW, Chu TY, et al: Epigenetic
silencing of PTPRR activates MAPK signaling, promotes metastasis
and serves as a biomarker of invasive cervical cancer. Oncogene.
32:15–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Meira DD, de Almeida VH, Mororó JS,
Nóbrega I, Bardella L, Silva RL, Albano RM and Ferreira CG:
Combination of cetuximab with chemoradiation, trastuzumab or MAPK
inhibitors: Mechanisms of sensitisation of cervical cancer cells.
Br J Cancer. 101:782–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
